These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33982642)

  • 1. Sex Differences in Opioid Use Disorder Prevalence and Multimorbidity Nationally in the Veterans Health Administration.
    Peltier MR; Sofuoglu M; Petrakis IL; Stefanovics E; Rosenheck RA
    J Dual Diagn; 2021; 17(2):124-134. PubMed ID: 33982642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study.
    Arout CA; Sofuoglu M; Bastian LA; Rosenheck RA
    J Womens Health (Larchmt); 2018 Aug; 27(8):1035-1044. PubMed ID: 29608126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid use disorder and homelessness in the Veterans Health Administration: The challenge of multimorbidity.
    Iheanacho T; Stefanovics E; Rosenheck R
    J Opioid Manag; 2018; 14(3):171-182. PubMed ID: 30044482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
    Kelly MM; Reilly E; Quiñones T; Desai N; Rosenheck R
    Drug Alcohol Depend; 2018 Feb; 183():111-117. PubMed ID: 29245103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of opioid use disorder and homelessness nationally in the veterans health administration.
    Manhapra A; Stefanovics E; Rosenheck R
    Drug Alcohol Depend; 2021 Jun; 223():108714. PubMed ID: 33865213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use disorder with chronic pain increases disease burden and service use.
    MacLean RR; Sofuoglu M; Stefanovics E; Rosenheck R
    Psychol Serv; 2023 Feb; 20(1):157-165. PubMed ID: 34968125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?
    Manhapra A; Stefanovics E; Rosenheck R
    Subst Abus; 2020; 41(1):110-120. PubMed ID: 31403914
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers.
    Goulet J; Cheng Y; Becker W; Brandt C; Sandbrink F; Workman TE; Ma P; Libin A; Shara N; Spevak C; Kupersmith J; Zeng-Treitler Q
    Front Public Health; 2023; 11():1148189. PubMed ID: 37124766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder.
    Joyce VR; Oliva EM; Garcia CC; Trafton J; Asch SM; Wagner TH; Humphreys K; Owens DK; Bounthavong M
    Addiction; 2023 Nov; 118(11):2203-2214. PubMed ID: 37465971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity among Veterans Diagnosed with PTSD in the Veterans Health Administration Nationally.
    Hefner K; Rosenheck R
    Psychiatr Q; 2019 Jun; 90(2):275-291. PubMed ID: 30847694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.
    Finlay AK; Wong JJ; Ellerbe LS; Rubinsky A; Gupta S; Bowe TR; Schmidt EM; Timko C; Burden JL; Harris AHS
    J Stud Alcohol Drugs; 2018 Nov; 79(6):909-917. PubMed ID: 30573022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Prevalence and HIV Screening History Among a Veterans Association Cohort of People with Opioid and Alcohol Use Disorders.
    McCann NC; Davenport MJ; Mandavia AD; Stein MD; Livingston NA
    J Gen Intern Med; 2024 Feb; 39(3):403-410. PubMed ID: 37848765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration.
    Barry DT; Sofuoglu M; Kerns RD; Wiechers IR; Rosenheck RA
    Psychiatry Res; 2015 Jun; 227(2-3):324-32. PubMed ID: 25863822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial.
    Auty SG; Barr KD; Frakt AB; Garrido MM; Strombotne KL
    Addiction; 2023 May; 118(5):870-879. PubMed ID: 36495477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study.
    Howell BA; Abel EA; Park D; Edmond SN; Leisch LJ; Becker WC
    J Gen Intern Med; 2021 May; 36(5):1264-1270. PubMed ID: 33179145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.
    Oliva EM; Harris AH; Trafton JA; Gordon AJ
    Drug Alcohol Depend; 2012 May; 122(3):241-6. PubMed ID: 22115887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
    Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
    Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of coprescribing anxiolytic medications with extensive prescription opioid use in Veterans Health Administration patients with metastatic cancer.
    Barry DT; Sofuoglu M; Kerns RD; Wiechers IR; Rosenheck RA
    J Opioid Manag; 2016; 12(4):259-68. PubMed ID: 27575827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
    De Aquino JP; Sofuoglu M; Stefanovics E; Rosenheck R
    Am J Drug Alcohol Abuse; 2019; 45(5):527-537. PubMed ID: 31112429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.